This content is machine translated Hormone receptor-positive breast carcinoma New option for adjunctive therapy The GnRH agonist triptorelin has been used successfully for some time in various areas, including the treatment of hormone-dependent prostate cancer. The drug is now also approved for adjuvant therapy…
View Post 7 min This content is machine translated Triple-negative stage I-III breast carcinoma Attack on an untouchable While targeted therapies are on the rise, there are still tumors that cannot (yet) benefit from this development. One such is triple-negative breast carcinoma. But even here, far from targeted…
View Post 1 min This content is machine translated Interdisciplinary therapy management Gynecologist and oncologist talking about ovarian cancer Although the prognosis for ovarian cancer patients has improved in recent years, it is still the most lethal gynecologic tumor [1, 2]. In a video interview, gynecologist Prof. Andreas Günthert,…
View Post 6 min This content is machine translated Therapy of metastatic HER2-positive breast carcinoma Is a cure possible soon? In recent years, the prognosis of metastatic HER2-positive breast carcinoma has been significantly improved by the development of new agents such as the antibody-drug conjugate (ADC) trastuzumab-deruxtecan and the HER2-targeted…
View Post 3 min This content is machine translated Breast Cancer News from the world of HER2-targeted treatment options Breast carcinoma is the most common malignant tumor in women. The prognosis of patients is determined primarily by the stage and biology of the disease. Innovative therapeutics and new treatment…
View Post 12 min This content is machine translated Venous thromboembolism Risks associated with hormone therapy Venous thromboembolism (VTE) is the third most common cardiovascular disease in Central Europe. They manifest as deep vein thrombosis in about two-thirds of cases and with symptoms of pulmonary embolism… CME-Test
View Post 3 min This content is machine translated Tumor Profiler Study Detailed profile of tumors In a study involving patients at the University Hospitals of Zurich and Basel, researchers are comprehensively and extremely precisely investigating the molecular and functional characteristics of tumors. This should enable…
View Post 3 min This content is machine translated Obstetrics First S3 guideline on vaginal delivery at term The birth of a human being is undoubtedly one of the key moments in life. In order to be able to care for women in childbirth at a high level,…
View Post 3 min This content is machine translated SARS-CoV-2 vaccination for nursing mothers Potential benefits outweigh safety concerns Although blanket routine vaccination of all breastfeeding women is not currently recommended, the potential benefits outweigh safety concerns in breastfeeding women at increased risk for COVID-19. The German Society for…
View Post 2 min This content is machine translated Researchers discover new connection How a signaling molecule influences the clinical course of ovarian cancer Ovarian cancer is the fifth leading cause of cancer-related death in women, primarily because it is usually detected late, metastasizes early to the abdomen, and available therapeutic agents are usually…
View Post 5 min This content is machine translated Ovarian tumors Of PARP inhibitors, new agents and sexuality The treatment of ovarian cancer is in a constant state of flux with the ongoing development of new drugs such as PARP inhibitors. With increasing experience in the use of…
